{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T04:54:57Z","timestamp":1794804897957,"version":"4.9.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"am","delay-in-days":284,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["UPR3212"],"award-info":[{"award-number":["UPR3212"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002334","name":"R\u00e9gion Grand Est","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","award":["UMR7200"],"award-info":[{"award-number":["UMR7200"]}],"id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","award":["UMS3415"],"award-info":[{"award-number":["UMS3415"]}],"id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","award":["UMS3286"],"award-info":[{"award-number":["UMS3286"]}],"id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-17-EURE-0022"],"award-info":[{"award-number":["ANR-17-EURE-0022"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.neuropharm.2021.108909","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T01:44:00Z","timestamp":1638582240000},"page":"108909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Antiallodynic action of phosphodiesterase inhibitors in a mouse model of peripheral nerve injury"],"prefix":"10.1016","volume":"205","author":[{"given":"Salim","family":"Megat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2464-3601","authenticated-orcid":false,"given":"Sylvain","family":"Hugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Journ\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Bohren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Lacaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Leli\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Doridot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Bourguignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Salvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Schlichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e9","family":"Freund-Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Barrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib1","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/odi.12275","article-title":"Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets","volume":"21","author":"Ahmad","year":"2015","journal-title":"Oral Dis."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0006-8993(98)01022-1","article-title":"Nitric oxide contributes to opioid release from glia during hypoxia","volume":"813","author":"Armstead","year":"1998","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2021.108909_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neurol.2018.08.005","article-title":"Pharmacological treatments of neuropathic pain: the latest recommendations","volume":"175","author":"Attal","year":"2019","journal-title":"Rev. Neurol."},{"issue":"9","key":"10.1016\/j.neuropharm.2021.108909_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/er.2013-1053","article-title":"Clinical and molecular genetics of the phosphodiesterases (PDEs)","volume":"35","author":"Azevedo","year":"2014","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108909_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.RES.69.3.677","article-title":"Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin. Evidence for two use-dependent binding sites","volume":"69","author":"Barber","year":"1991","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuropharm.2021.108909_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuroscience.2011.12.041","article-title":"Tests and models of nociception and pain in rodents","volume":"211","author":"Barrot","year":"2012","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108909_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/157488909789104794","article-title":"From antidepressant drugs to beta-mimetics: preclinical insights on potential new treatments for neuropathic pain","volume":"4","author":"Barrot","year":"2009","journal-title":"Recent Pat. CNS Drug Discov."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2217\/fnl.09.82","article-title":"Antidepressant treatment of neuropathic pain: looking for the mechanism","volume":"5","author":"Barrot","year":"2010","journal-title":"Future Neurol."},{"key":"10.1016\/j.neuropharm.2021.108909_bib88","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopsych.2014.08.004","article-title":"The anterior cingulate cortex is a critical hub for pain-induced depression","volume":"77","author":"Barthas","year":"2015","journal-title":"Biol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108909_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.biopsych.2007.06.016","article-title":"Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia","volume":"63","author":"Benbouzid","year":"2008","journal-title":"Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2021.108909_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejpain.2007.10.002","article-title":"Sciatic nerve cuffing in mice: a model of sustained neuropathic pain","volume":"12","author":"Benbouzid","year":"2008","journal-title":"Eur. J. Pain"},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1460-9568.2004.03459.x","article-title":"Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue","volume":"20","author":"Binder","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2021.108909_bib13","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1021\/acs.jmedchem.7b01804","article-title":"Orally available soluble epoxide hydrolase\/phosphodiesterase 4 dual inhibitor treats inflammatory pain","volume":"61","author":"Bl\u00f6cher","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF00381071","article-title":"Is Phosphodiesterase inhibition a new mechanism of antidepressant action?","volume":"238","author":"Bobon","year":"1988","journal-title":"Eur. Arch. Psychiatry Neurol. Sci."},{"issue":"7","key":"10.1016\/j.neuropharm.2021.108909_bib15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ejpain.2009.11.014","article-title":"Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia","volume":"14","author":"Bohren","year":"2010","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2021.108909_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nbd.2013.08.012","article-title":"Antidepressants suppress neuropathic pain by a peripheral \u03b22-adrenoceptor mediated anti-TNF\u03b1 mechanism","volume":"60","author":"Bohren","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2021.108909_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2019.05.026","article-title":"Design and synthesis of 3-aminophthalazine derivatives and structural analogues as PDE5 inhibitors: anti-allodynic effect against neuropathic pain in a mouse model","volume":"177","author":"Bollenbach","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"33","key":"10.1016\/j.neuropharm.2021.108909_bib18","doi-asserted-by":"crossref","first-page":"22430","DOI":"10.1074\/jbc.M803306200","article-title":"Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts","volume":"283","author":"Bruss","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.neuropharm.2021.108909_bib19","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/ejn.14093","article-title":"Peripheral delta opioid receptors mediate duloxetine antiallodynic effect in a mouse model of neuropathic pain","volume":"48","author":"Ceredig","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108909_bib20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnmol.2019.00324","article-title":"Peripheral delta opioid receptors mediate formoterol anti-allodynic effect in a mouse model of neuropathic pain","volume":"12","author":"Ceredig","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108909_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejmech.2018.09.021","article-title":"Novel amide derivatives of 1, 3-dimethyl-2, 6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4\/7 inhibitors: a new approach for the treatment of pain","volume":"158","author":"Ch\u0142o\u0144-Rzepa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2021.108909_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2013.12.016","article-title":"The antiallodynic action of nortriptyline and terbutaline is mediated by \u03b22adrenoceptors and \u03b4 opioid receptors in the ob\/ob model of diabetic polyneuropathy","volume":"1546","author":"Choucair-Jaafar","year":"2014","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2021.108909_bib23","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1476-5381.2009.00510.x","article-title":"\u03b22-Adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment","volume":"158","author":"Choucair\u2010Jaafar","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108909_bib24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neuint.2011.08.012","article-title":"Combined anti-inflammatory effects of \u03b22-adrenergic agonists and PDE4 inhibitors on astrocytes by upregulation of intracellular cAMP","volume":"59","author":"Christiansen","year":"2011","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108909_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.niox.2011.06.004","article-title":"Pain and analgesia: the dual effect of nitric oxide in the nociceptive system","volume":"25","author":"Cury","year":"2011","journal-title":"Nitric Oxide - Biol Chem"},{"key":"10.1016\/j.neuropharm.2021.108909_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neubiorev.2018.09.026","article-title":"G protein-coupled receptor heteromers are key players in substance use disorder","volume":"106","author":"Derouiche","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00429-014-0717-9","article-title":"A mu\u2013delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks","volume":"220","author":"Erbs","year":"2015","journal-title":"Brain Struct. Funct."},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108909_bib28","doi-asserted-by":"crossref","first-page":"L675","DOI":"10.1152\/ajplung.2000.279.4.L675","article-title":"beta-adrenergic agonists exert their \u201canti-inflammatory\u201d effects in monocytic cells through the IkappaB\/NF-kappaB pathway","volume":"279","author":"Farmer","year":"2000","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for \u03b4- and \u03bc-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108909_bib30","article-title":"Cyclic nucleotide phosphodiesterases: relating structure and function","volume":"1\u201352","author":"Francis","year":"2001","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00210-019-01779-z","article-title":"cGMP: a unique 2nd messenger molecule\u2013recent developments in cGMP research and development","volume":"393","author":"Friebe","year":"2020","journal-title":"N-S Arch Pharmacol"},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108909_bib33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/brv.12020","article-title":"Biological roles of cAMP: variations on a theme in the different kingdoms of life","volume":"88","author":"Gancedo","year":"2013","journal-title":"Biol. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2021.108909_bib35","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3892\/ijmm.2016.2763","article-title":"The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK\/CCL2 pathway in bone cancer pain","volume":"38","author":"Guo","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2021.108909_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jep.2015.03.015","article-title":"Antiplasmodial and anti-inflammatory effects of an antimalarial remedy from the Wayana Amerindians, French Guiana: takamalaim\u00eb (Psidium acutangulum Mart. Ex DC., Myrtaceae)","volume":"166","author":"Hou\u00ebl","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2009.09.007","article-title":"Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown","volume":"35","author":"Houslay","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3349\/ymj.2010.51.1.82","article-title":"Effect of sildenafil on neuropathic pain and hemodynamics in rats","volume":"51","author":"Huang","year":"2010","journal-title":"Yonsei Med. J."},{"issue":"7","key":"10.1016\/j.neuropharm.2021.108909_bib39","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.pain.2012.03.025","article-title":"Chronic compression or acute dissociation of dorsal root ganglion induces cAMP-dependent neuronal hyperexcitability through activation of PAR2","volume":"153","author":"Huang","year":"2012","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib40","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3892\/mmr.2015.4713","article-title":"Intrathecal injection of phosphodiesterase 4B-specific siRNA attenuates neuropathic pain in rats with L5 spinal nerve ligation","volume":"13","author":"Ji","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2012.07.050","article-title":"Comparison of cAMP-specific phosphodiesterase mRNAs distribution in mouse and rat brain","volume":"525","author":"Johansson","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"19","key":"10.1016\/j.neuropharm.2021.108909_bib42","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1016\/j.bmc.2009.08.014","article-title":"Synthesis and biological evaluation of novel phthalazinone derivatives as topically active phosphodiesterase 4 inhibitors","volume":"17","author":"Kagayama","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2021.108909_bib43","first-page":"58","article-title":"Protective effect of co-administration of curcumin and sildenafil in alcohol induced neuropathy in rats","volume":"805","author":"Kaur","year":"2017","journal-title":"J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2021.108909_bib44","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments","volume":"165","author":"Keravis","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108909_bib45","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3389\/fphar.2017.00885","article-title":"Rolipram, a selective phosphodiesterase 4 inhibitor, ameliorates mechanical hyperalgesia in a rat model of chemotherapy-induced neuropathic pain through inhibition of inflammatory cytokines in the dorsal root ganglion","volume":"8","author":"Kim","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.neuropharm.2021.108909_bib46","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nn.2407","article-title":"Unmasking the tonic-aversive state in neuropathic pain","volume":"12","author":"King","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108909_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","article-title":"Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights","volume":"338","author":"Kremer","year":"2016","journal-title":"Neuroscience"},{"issue":"46","key":"10.1016\/j.neuropharm.2021.108909_bib48","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1523\/JNEUROSCI.1004-18.2018","article-title":"A dual noradrenergic mechanism for the relief of neuropathic allodynia by the antidepressant drugs duloxetine and amitriptyline","volume":"38","author":"Kremer","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108909_bib49","doi-asserted-by":"crossref","DOI":"10.1177\/1744806920912931","article-title":"Delta opioid receptors are essential to the antiallodynic action of \u03922-mimetics in a model of neuropathic pain","volume":"16","author":"Kremer","year":"2020","journal-title":"Mol. Pain"},{"issue":"17","key":"10.1016\/j.neuropharm.2021.108909_bib50","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1021\/jm300514y","article-title":"Design, synthesis, and pharmacological evaluation of N -Acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors","volume":"55","author":"K\u00fcmmerle","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2021.108909_bib34","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.103.052613","article-title":"Evidence for an involvement of supraspinal \u03b4-and spinal \u03bc-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats","volume":"307","author":"Marchand","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108909_bib52","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00345-005-0015-5","article-title":"Phosphodiesterase inhibitors in female sexual dysfunction","volume":"23","author":"Mayer","year":"2005","journal-title":"World J. Urol."},{"key":"10.1016\/j.neuropharm.2021.108909_bib53","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.taap.2018.05.013","article-title":"Antinociceptive effect of tadalafil in various pain models: involvement of opioid receptors and nitric oxide cyclic GMP pathway","volume":"352","author":"Mehanna","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2021.108909_bib55","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","article-title":"Antidepressants and pain","volume":"27","author":"Mic\u00f3","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-10-29","article-title":"Imaging cytoplasmic cAMP in mouse brainstem neurons","volume":"10","author":"Mironov","year":"2009","journal-title":"BMC Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108909_bib57","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/13543784.2019.1571582","article-title":"Experimental and investigational phosphodiesterase inhibitors in development for asthma","volume":"28","author":"Ntontsi","year":"2019","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuropharm.2021.108909_bib58","first-page":"391","article-title":"Phosphodiesterase inhibitors in the treatment of inflammatory diseases","author":"Page","year":"2011","journal-title":"PDE Drug Targets"},{"issue":"12","key":"10.1016\/j.neuropharm.2021.108909_bib59","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1111\/j.1460-9568.2004.03799.x","article-title":"Inhibition of tumour necrosis factor-\u03b1 by antisense targeting produces immunophenotypical and morphological changes in injury-activated microglia and macrophages","volume":"20","author":"Pearse","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"3\u20134","key":"10.1016\/j.neuropharm.2021.108909_bib60","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0891-0618(00)00097-1","article-title":"Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and [3H] rolipram binding autoradiography: comparison with monkey and rat brain","volume":"20","author":"P\u00e9rez-Torres","year":"2000","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2021.108909_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2020.00259","article-title":"Inhaled phosphodiesterase 4 (PDE4) inhibitors for inflammatory respiratory diseases","volume":"11","author":"Phillips","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib62","first-page":"34","article-title":"The potential of phosphodiesterase 4 inhibitors for the treatment of depression: opportunities and challenges","volume":"5","author":"Renau","year":"2004","journal-title":"Curr Op Invest Dr (Lond, En: 2000)"},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharep.2018.10.002","article-title":"Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model","volume":"71","author":"Rojewska","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2021.108909_bib64","first-page":"103","article-title":"Nitric oxide-mediated pain processing in the spinal cord","author":"Schmidtko","year":"2015","journal-title":"Pain Control"},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"The IASP classification of chronic pain for ICD-11: chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108909_bib66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0192-0561(93)90052-Z","article-title":"The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-\u03b1 production by human mononuclear cells","volume":"15","author":"Semmler","year":"1993","journal-title":"Int. J. Immunopharm."},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108909_bib67","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/emboj\/17.4.886","article-title":"Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal","volume":"17","author":"Simonin","year":"1998","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108909_bib68","first-page":"886","article-title":"Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions","volume":"17","author":"Soderling","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.neuropharm.2021.108909_bib69","doi-asserted-by":"crossref","DOI":"10.1152\/jn.00503.2005","article-title":"cAMP and cGMP contribute to sensory neuron hyperexcitability and hyperalgesia in rats with dorsal root ganglia compression","author":"Song","year":"2006","journal-title":"J. Neurophysiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib70","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0304-3940(02)00938-2","article-title":"Dual effects of spinally delivered 8-bromo-cyclic guanosine mono-phosphate (8-bromo-cGMP) in formalin-induced nociception in rats","volume":"332","author":"Tegeder","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2021.108909_bib72","first-page":"92","article-title":"Antihyperalgesic and antiallodynic effects of mianserin on diabetic neuropathic pain: a study on mechanism of action","volume":"756","author":"\u00dc\u00e7el","year":"2015","journal-title":"J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00011-006-6109-8","article-title":"Role of NO\/cGMP\/KATP pathway in antinociceptive effect of sildenafil in zymosan writhing response in mice","volume":"56","author":"Vale","year":"2007","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2021.108909_bib74","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuroscience.2011.07.039","article-title":"Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice","volume":"193","author":"Wang","year":"2011","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108909_bib75","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1476-5381.2011.01297.x","article-title":"Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?","volume":"163","author":"Wattiez","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib76","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neulet.2008.03.087","article-title":"Rolipram attenuates acute oligodendrocyte death in the adult rat ventrolateral funiculus following contusive cervical spinal cord injury","volume":"438","author":"Whitaker","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-013-0023-0","article-title":"Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases","volume":"3","author":"Wittmann","year":"2013","journal-title":"Dermatol. Ther."},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108909_bib78","first-page":"13","article-title":"An update on the pharmacologic management and treatment of neuropathic pain","volume":"30","author":"Wright","year":"2017","journal-title":"J Am Acad PAs"},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108909_bib79","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.nbd.2008.11.003","article-title":"\u03b22-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain","volume":"33","author":"Yalcin","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108909_bib80","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.21542","article-title":"\u03b22\u2010adrenoceptors are critical for antidepressant treatment of neuropathic pain","volume":"65","author":"Yalcin","year":"2009","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108909_bib81","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2009.10.008","article-title":"Chronic treatment with agonists of \u03b22-adrenergic receptors in neuropathic pain","volume":"221","author":"Yalcin","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108909_bib82","article-title":"The sciatic nerve cuffing model of neuropathic pain in mice","volume":"89","author":"Yalcin","year":"2014","journal-title":"JoVE"},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108909_bib83","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1046\/j.1471-4159.1997.69062397.x","article-title":"Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-Affinity cyclic AMP phosphodiesterase (PDE4) in rat brain","volume":"69","author":"Ye","year":"1997","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108909_bib84","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/npp.2008.184","article-title":"Postsynaptic \u03b1-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior","volume":"34","author":"Zhang","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108909_bib85","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3389\/fphar.2020.01078","article-title":"Mu opioid receptor heterodimers emerge as novel therapeutic targets: recent progress and future perspective","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108909_bib86","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1527-3458.2001.tb00206.x","article-title":"The antidepressant and antiinflammatory effects of rolipram in the central nervous system","volume":"7","author":"Zhu","year":"2001","journal-title":"CNS Drug Rev."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821004664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821004664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:12:45Z","timestamp":1778703165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821004664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":86,"alternative-id":["S0028390821004664"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108909","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiallodynic action of phosphodiesterase inhibitors in a mouse model of peripheral nerve injury","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108909"}}